MAXIMIZING ONCOLOGY INVESTIGATION WITH BUILT-IN KRAS ASSAY SERVICES AND RAS ASSAYS

while in the promptly evolving area of oncology investigation, precise and productive mutation screening is critical for acquiring qualified therapies. The KRAS companies Platform performs a pivotal function Within this landscape by providing detailed alternatives for KRAS mutation profiling and Assessment. KRAS mutations, located in close to ninet